Hydrogen-Bond Patterns of Dialkylpyridone Iron Chelators and Their 1:1 Formic Acid Solvates: Description, Prediction, and Role in Crystal Packing
- 1 September 1993
- journal article
- website
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 82 (9) , 901-911
- https://doi.org/10.1002/jps.2600820908
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Crystal Structures of a New Oral Iron Chelator, 1,2-Dimethyl-3-hydroxy-4- pyridone, and its Solvates with Acetic Acid and Formic AcidJournal of Pharmaceutical Sciences, 1992
- Solid State Properties of an Oral Iron Chelator, 1,2-Dimethyl-3-hydroxy-4-pyridone, and Its Acetic Acid Solvate. I: Physicochemical Characterization, Intrinsic Dissolution Rate, and Solution ThermodynamicsJournal of Pharmaceutical Sciences, 1991
- Aluminum and gallium complexes of 1-ethyl-3-hydroxy-2-methyl-4-pyridinone: a new exoclathrate matrixInorganic Chemistry, 1989
- Synthetic methods and in vitro iron binding studies of the novel 1-alkyl-2-ethyl-3-hydroxypyrid-4-one iron chelatorsInorganica Chimica Acta, 1988
- Physical and structural studies of N-substituted-3-hydroxy-2-methyl-4(1H)-pyridinonesCanadian Journal of Chemistry, 1988
- Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.BMJ, 1987
- Structure/iron binding activity of 1-hydroxypyrid-2-one chelators intended for clinical useInorganica Chimica Acta, 1987
- Directional hydrogen bonding to sp2- and sp3-hybridized oxygen atoms and its relevance to ligand-macromolecule interactionsJournal of the American Chemical Society, 1984
- LONG‐TERM DESFERRIOXAMINE THERAPY IN THALASSEMIAAnnals of the New York Academy of Sciences, 1974
- Long-term Chelation Therapy in Thalassaemia Major: Effect on Liver Iron Concentration, Liver Histology, and Clinical ProgressBMJ, 1974